Join to View Full Profile
Bristol-Myers SquibbRoute 206 and Provinceline RoadPrinceton, NJ 08540
Phone+1 609-252-3244
Dr. Birkhofer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
New York Medical CollegeClass of 1983
Publications & Presentations
PubMed
- 46 citationsA Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous Gatifloxacin in Healthy Adult MenDiptee A. Gajjar, Frank LaCreta, Howard Uderman, Georgia Kollia, Glenn F. Duncan
Pharmacotherapy. 2000-06-01 - 450 citationsCTLA4Ig-mediated blockade of T cell costimulation in patients with psoriasis vulgarisJudith R. Abrams, Mark Lebwohl, Cynthia Guzzo, Brian V. Jegasothy, Michael T. Goldfarb
The Journal of Clinical Investigation. 1999-05-01 - 16 citationsBioavailability and phase II study of oral UFT plus leucovorin in patients with relapsed or refractory colorectal cancerNeal J. Meropol, Daryl S. Sonnichsen, Martin J. Birkhofer, Irene Ferreira, D Noel
Cancer Chemotherapy and Pharmacology. 1999-01-01
Press Mentions
Analysis of Patients with Prior Gastrectomy Treated with LONSURF® (Trifluridine and Tipiracil) Published in JAMA OncologyOctober 10th, 2019
Taiho Oncology and Servier Present LONSURF® (Trifluridine and Tipiracil) Data at the 2019 ASCO Annual MeetingJune 3rd, 2019
NCCN Awards Grants to Investigators to Study Trifluridine and Tipiracil in Various CancersMarch 14th, 2019- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
